The Dark Side of the Double Helix:
Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes underway in life science. Trained in microbiology and genetics, Andrew has continually worked at the forefront of life science in industry and academia. He is faculty at Singularity University, where he co-chaired the Biotechnology and Bioinformatics track and now helps startup biotechnology companies organize and launch. He is also a fellow at the University of Ottawa, Institute for Science, Society, and Policy, and the founder of the world’s first cooperative biotechnology company, the Pink Army Cooperative, which is working to create open source cancer therapies for cancer. Andrew has given dozens of invited talks related to synthetic biology, for groups that include Intel Inc., the FBI, and the United Nations.